Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 43, Issue 12, 2008, Pages 1402-1409

  Peden Adams, Margie M ^a,b   Eudaly, Jackie G ^a,b   Lee, A Michelle ^a,b   Miller, Julie ^a   Keil, Deborah E ^c   Gilkeson, Gary S ^a,b,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Autoimmune; Developmental; Immune; MRL + +; TCE; Trichloroethylene

Indexed keywords

ANESTHETICS; ANTIGENS; CELL CULTURE; CELL PROLIFERATION; DIFFRACTIVE OPTICAL ELEMENTS; DISEASE CONTROL; POPULATION STATISTICS; POTABLE WATER; TRICHLOROETHYLENE;

AUTOIMMUNE; DEVELOPMENTAL; IMMUNE; MRL +/+; TCE;

CYTOLOGY;

CD45 ANTIGEN; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GESTATIONAL AGE; IMMUNOTOXICITY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PROTEINURIA; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL PROLIFERATION; FEMALE; GENOTYPE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED MRL LPR; T-LYMPHOCYTES; TRICHLOROETHYLENE;

MURINAE; MUS;

EID: 51549113211     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934520802232063     Document Type: Article

References (32)

1. ATSDR Toxicological Profile for Trichloroethylene (update). ATSDR. Atlanta: Agency for Toxic Substances and Disease Registry, 1997. http://toxprof.crcpress.com or www.atsdr.cdc.gov/toxpro2.html.
2. Barton, H.A.; Clewell, H.J. Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment. Environ. Health Perspect. 2000, 3 (108) 2, 323-334.
3. Sanders, V.M.; Tucker, A.N.; White, K.L.; Kauffmann, B.M.; Hallett, P.; Carchman, R.A.; Borzelleca, J.F.; Munson, A.E. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in drinkingwater. Toxicol. Appl. Pharmacol. 1982, 62, 358-368.
4. Byers, V.S.; Levin, A.S.; Onzonoff, D.M.; Baldwin, R.W. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukemia. Cancer Immonol. Immunother. 1988, 27, 77-81.
5. Gist, G.L.; Burg, J.R. Trichloroethylene - a review of the literature from a health effects perspective. Toxicol. Ind. Health 1995, 11, 253-307.
6. Wright, P.F.; Thomas, W.D.; Stacey, N.H. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicology 1991, 70, 231-242.
7. Kaneko, T.; Saeguse, M.; Tasaka, K.; Sato, A. Immuntoxicity of trichlorethylene: a study with MRL lpr/lpr mice. J. Appl. Toxicol. 2000, 20, 471-475.
8. Peden-Adams, M.M.; EuDaly, J.G.; Heesemann, L.M.; Smythe, J.; Miller, J.; Gilkeson, G.S.; Keil, D.E. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. Journal Environ. Sci. Health, Part A, 2006, 41, 249-271.
9. Flindt-Hansen H.; Isager, H. Scleroderma after occupational exposure to trichloroethylene and trichlorethane. Acta Derm Venereol. 1987, 67, 263-264.
10. Kilburn, K.H.; Warshaw, R.H. Prevalence of symptoms of systemic lupus erythematous (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ. Res. 1992, 57, 1-9.
11. Khan, M.F.; Kaphalia, B.S.; Prabhakar, B.S.; Kanz, M.F.; Ansari, G.A.S. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol. Appl. Pharmacol. 1995, 134, 155-160.
12. Wallace, S.; Gilkeson, G.; Peden-Adams, M.M.; EuDaly, J.; Keil, D.E. A comparative study evaluating the immunological effects of trichloroethylene in NZB/NZW and B6C3F1 mice. Toxicologist 2001, 60 (S-1), 141.
13. Griffin, J.M.; Blossom, S.J.; Jackson, S.K.; Gilbert, K.M.; Pumford, N.R. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 2000, 46, 123-137.
14. Griffin, J.M.; Gilbert, K.M.; Pumford, N.R. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol. Sci. 2000, 54, 384-389.
15. Blossom S.J.; Pumford N.R.; Gilbert K.M. Activation and attenuation of apoptosis of CD4+ T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J. Autoimmun. 2004, 23, 211-220.
16. Barton, H.A.; Das, S. Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene. Regul. Toxicol. and Pharmacol. 1996, 24(3), 269-285.
17. Gilkeson, G.; Ruiz, P.; Alexander, A.; Pippen, A.; Lefkowith, J.; Pisetsky, D. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med. 1996, 183, 1389-1398.
18. Pollard, K.M.; Pearson, D.L.; Hultman, P.; Deane, T.N.; Lindh, U.; Kono, D.H. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environ. Health Perspect. 2001, 109, 27-33.
19. Deapen, D.; Escalante, A.; Weinrib, L.; Horwitz, D.; Bachman, B.; Roy-Burman, P.; Walker, A.; Mack, T.M. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992, 35, 311-318.
20. Pollard, K.M.; Pearson, D.L.; Hultman, P.; Hildebrandt, B.; Kono, D.H. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ. Health. Perspect. 1999, 107(5), 729-735.
21. Choudhary, D.; Jansson, I.; Stoilov, I.; Sarfarazi, M.; Schenkman, J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005, 436, 50-61.
22. Fisher, J.W.; Whittaker, T.A.; Taylor, D.H.; Clewell, H.J.; Andersen, M.E. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 1990, 102, 497-451.
23. Gilkeson, G.S.; Pippen, A.M.; Pisetsky, D.S. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin Invest. 1995, 95(3),1398-1402.
24. Mackworth-Young, C.; Schwartz, R.S. Autoantibodies to DNA. Crit. Rev. Immunol. 1988, 8, 147-173.
25. Pisetsky, D. S. Anti-DNA antibodies in systemic lupus erythematosus. Rheum. Dis. Clin. N. Amer. 1992, 18, 437-454.
26. Lefkowith, J. B.; Gilkeson, G.S. Nephritogenic autoantibodies inlupus. Arthritis Rheum. 1996, 39, 894.
27. Pankewycz, O.G.; Migliorini, P.; Madaio, M.P. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J. Immunol. 1987, 139, 3287.
28. Winfield, J. B.; Faiferman, I.; Koffler, D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus: association of high avidity anti-native DNA antibody with glomerulonephritis. J. Clin. Invest. 1977, 59, 90.
29. Yoshida, H.; Kohno, A.; Ohta, K.; Hirose, S.; Maruyama, N.; Shirai, T. 1981. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB_NZW)F1 _NZW backcross mice. J. Immunol. 1981, 127, 33.
30. Izui, S.; Kelley, V.E.; Masuda, K.; Yoshida, H.; Roths J.B.;Murphy, E.D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 1984, 133, 227.
31. Appel, A. E.; Sablay, L.B.; Golden, R.A.: Barland, P.; Grayzel, A.I.; Bank, N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am. J. Med. 1978, 64, 274.
32. Sekine, H.; Watanabe, H.; Gilkeson, G.S. Enrichment of antiglomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J. Immunol. 2004, 172(6), 3913-3921.